Skip to main content

Advertisement

Table 1 (abstract P114). See text for description

From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)

Parameters Uveitis, yes n=32 Uveitis, no n=143 ла
Onset age, years 3.9 (2.1; 6.2) 5.5 (2.5; 10.5) 0.033
ANA positivity, n (%) 15/26 (57.7) 26/72 (36.1) 0.056
Ongoing methotrexate, n (%) 26 (81.3) 103 (72.0) 0.284
Time before 1st biologics, months 2.9 (1.5; 5.3) 2.2 (1.0; 5.2) 0.343
Remission duration, months 6.5 (2.4; 6.9) 13.1 (6.5; 28.0) 0.078
First significant flare, n (%) 14 (43.8) 24/142 (16.9) 0.0009
Time before first significant flare, months 33.0 (16.7; 61.5) 48.6 (26.4; 65.7) 0.023
Switching of the first biologic, n (%) 7 (21.9) 18/142 (12.7) 0.180
Time before switching of the first biologics, months 49.0 (24.5; 62.1) 52.3 (35.0; 66.2) 0.186